TAKE THIS POLL |
|
|
- FDA actions in brief, August 2008 (Concerta, Avodart, Prandimet, Trivaris, Reclast, Requip XL, Aciphex, Aptivus, Kinrix, Pentacel, Durezol) 7 Aug 2008 04:30 GMT
... the signs and symptoms of idiopathic Parkinson disease (PD). Rabeprazole ( Aciphex, Eisai) was approved ... for the short-term (≤8 wk) treatment of gastroesophageal reflux disease (GERD) in adolescents aged ≥12 years. ...
- XenoPort Reports Second Quarter Financial Results 6 Aug 2008 20:51 GMT
... a Phase 2a clinical trial of its second product candidate, XP19986, in patients with gastroesophageal reflux disease, or GERD, and is currently conducting a second Phase 2 clinical trial in GERD ...
- Eisai Gets Win in Aciphex Suit 5 Aug 2008 21:15 GMT
... case over proposed generic versions of its proton pump inhibitor Aciphex, a treatment for gastroesophageal reflux disease. This article is viewable by subscribers only. To view this article, please select an ...
- Addex Pharmaceuticals (CH) - Disclosure of Shareholdings in Accordance with Stock Market Rules 5 Aug 2008 19:30 GMT
... has demonstrated clinically and statistically significant efficacy in separate Phase IIa clinical trials in gastroesophageal reflux disease (GERD) patients and migraine headache patients and has potential in additional indications. The Addex ...
- Pain in chest, upper abdomen an ominous sign 5 Aug 2008 17:53 GMT
... likely to be hospitalized for "ischemic" heart disease - the type of heart disease caused ... endoscopy results have not excluded those with gastroesophageal reflux disease (GERD) or ulcers, they add. "Thus, ...
1 - 25 of 53 next >
News by PR Newswire
|